The Montreal team's IV ketamine service for Treatment-Resistant Depression (TRD) resulted in rapid improvements in depression and suicidality in approximately 50% of patients, with these effects generally fading within days or weeks of the last dose.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (3)

• depression concept
• treatment-resistant depression concept
• suicidality concept